Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Botox in Vulvar Vestibulitis
NCT00119886Phase 4Unknown
- Sponsor
- Rigshospitalet
- Start
- Apr 2005
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of botulinum toxin type A in vulvar vestibulitis syndrome (VVS), sponsored by Rigshospitalet. Primary endpoint: Visual Analogue Scale for Vulvar Pain. Status: unknown.
02
Drugs
botulinum toxin type A
03
Conditions
vulvar vestibulitis syndrome (VVS)
Beyond the preview
Go deeper on NCT00119886.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00119886.